Nucleic Acid Therapeutics

Papers
(The H4-Index of Nucleic Acid Therapeutics is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study89
The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy81
Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Tr55
Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells41
Transcriptome-Wide Off-Target Effects of Steric-Blocking Oligonucleotides41
Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives33
Delivery of RNA Therapeutics: The Great Endosomal Escape!31
Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics29
Challenges and Opportunities for Nucleic Acid Therapeutics28
Oligonucleotides and the COVID-19 Pandemic: A Perspective26
High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p25
Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer23
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia22
Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy21
Technical Considerations for Use of Oligonucleotide Solution API20
Researcher's Perceptions on Publishing “Negative” Results and Open Access19
Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence Features19
miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy19
Delivery of Antisense Oligonucleotides to the Cornea19
0.021744012832642